Monitoring of Vital Signs During Skin-to-skin Holding by Mothers of Their Preterm Babies
NCT ID: NCT02231801
Last Updated: 2015-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2014-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mother-Infant Dyad
Skin-to-skin holding of preterm infants by their mothers
Mother-Infant Dyad
Skin-to-skin holding of preterm infants by their mothers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mother-Infant Dyad
Skin-to-skin holding of preterm infants by their mothers
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gestational age between 30 0/7 weeks and 34 6/7 weeks gestation
* only one infant of a multiple gestation
* plan by family to do kangaroo care during NICU stay
* any major congenital anomalies
* sepsis and/or any other serious clinical complication precluding kangaroo care
Exclusion Criteria
* gestational age less that 29 6/7 weeks or greater than 35 0/7 weeks
30 Weeks
35 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ian Holzman, MD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PD14-03941
Identifier Type: -
Identifier Source: secondary_id
GCO 14-1323
Identifier Type: -
Identifier Source: org_study_id